Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model

Background: Kawasaki disease is treated by immunoglobulin therapy, which has adverse side effects like renal damage. Aims: The aim of the present study was to explore the effectiveness of triptolide, a compound derived from threewingnut that has anti-inflammatory effects, on the treatment of Kawa...

Full description

Bibliographic Details
Main Authors: Zong-Ting Yan, Jian-Wen Zou
Format: Article
Language:English
Published: Galenos Publishing House 2013-06-01
Series:Balkan Medical Journal
Subjects:
Online Access:http://balkanmedicaljournal.org/text.php?lang=en&id=399
id doaj-70d1f40f508f480791236163d82a08b2
record_format Article
spelling doaj-70d1f40f508f480791236163d82a08b22020-11-25T00:46:28ZengGalenos Publishing HouseBalkan Medical Journal2146-31232146-31312013-06-0130222522810.5152/balkanmedj.2013.7963Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse ModelZong-Ting Yan0Jian-Wen Zou1Department of Clinical Laboratory, Shandong Province Hospital of Traditional Chinese Medicine, Jinan, ChinaDepartment of Clinical Laboratory, Shandong Provincial Hospital, Jinan, ChinaBackground: Kawasaki disease is treated by immunoglobulin therapy, which has adverse side effects like renal damage. Aims: The aim of the present study was to explore the effectiveness of triptolide, a compound derived from threewingnut that has anti-inflammatory effects, on the treatment of Kawasaki disease in a mouse model. Study Design: Animal experiment. Methods: A mouse model of Kawasaki disease was established through exposure to Candida albicans by intraperitoneal injection. Exposed mice were then randomly divided into several groups (each n=15): model group (saline-treated), low- or high-dose triptolide groups (0.2 mg/kg or 0.4 mg/kg, respectively), and IVIG (high-dose immunoglobulin) group (1 g/kg body weight). Unexposed mice served as an additional control group. Nine weeks from the initial exposure, mice were euthanised and coronary tissues and blood samples were harvested. The rate of apoptosis was detected by TUNEL, and ICAM-1 expression was detected by immunohistochemistry in coronary endothelial cells. Serum TNF-α levels were detected by ELISA. Results: Compared to mice in the (unexposed) control group, apoptosis of endothelial cells, ICAM-1 expression, and serum TNF-α levels were significantly increased in all exposed mice (p<0.05), confirming the presence of disease. However, treatment with triptolide or IVIG significantly lowered these measures compared to untreated exposed mice (model group; p<0.05). Conclusions: Triptolide treatment reduces markers of coronary endothelial inflammation in a mouse model of Kawasaki disease, similar to IVIG treatment, and therefore may be a useful alternative therapy for this disease.http://balkanmedicaljournal.org/text.php?lang=en&id=399TriptolideKawasaki diseaseendothelial cellsapoptosisICAM-1TNF-α
collection DOAJ
language English
format Article
sources DOAJ
author Zong-Ting Yan
Jian-Wen Zou
spellingShingle Zong-Ting Yan
Jian-Wen Zou
Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
Balkan Medical Journal
Triptolide
Kawasaki disease
endothelial cells
apoptosis
ICAM-1
TNF-α
author_facet Zong-Ting Yan
Jian-Wen Zou
author_sort Zong-Ting Yan
title Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
title_short Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
title_full Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
title_fullStr Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
title_full_unstemmed Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
title_sort triptolide as an alternative to ivig therapy for kawasaki disease in a mouse model
publisher Galenos Publishing House
series Balkan Medical Journal
issn 2146-3123
2146-3131
publishDate 2013-06-01
description Background: Kawasaki disease is treated by immunoglobulin therapy, which has adverse side effects like renal damage. Aims: The aim of the present study was to explore the effectiveness of triptolide, a compound derived from threewingnut that has anti-inflammatory effects, on the treatment of Kawasaki disease in a mouse model. Study Design: Animal experiment. Methods: A mouse model of Kawasaki disease was established through exposure to Candida albicans by intraperitoneal injection. Exposed mice were then randomly divided into several groups (each n=15): model group (saline-treated), low- or high-dose triptolide groups (0.2 mg/kg or 0.4 mg/kg, respectively), and IVIG (high-dose immunoglobulin) group (1 g/kg body weight). Unexposed mice served as an additional control group. Nine weeks from the initial exposure, mice were euthanised and coronary tissues and blood samples were harvested. The rate of apoptosis was detected by TUNEL, and ICAM-1 expression was detected by immunohistochemistry in coronary endothelial cells. Serum TNF-α levels were detected by ELISA. Results: Compared to mice in the (unexposed) control group, apoptosis of endothelial cells, ICAM-1 expression, and serum TNF-α levels were significantly increased in all exposed mice (p<0.05), confirming the presence of disease. However, treatment with triptolide or IVIG significantly lowered these measures compared to untreated exposed mice (model group; p<0.05). Conclusions: Triptolide treatment reduces markers of coronary endothelial inflammation in a mouse model of Kawasaki disease, similar to IVIG treatment, and therefore may be a useful alternative therapy for this disease.
topic Triptolide
Kawasaki disease
endothelial cells
apoptosis
ICAM-1
TNF-α
url http://balkanmedicaljournal.org/text.php?lang=en&id=399
work_keys_str_mv AT zongtingyan triptolideasanalternativetoivigtherapyforkawasakidiseaseinamousemodel
AT jianwenzou triptolideasanalternativetoivigtherapyforkawasakidiseaseinamousemodel
_version_ 1725265301349597184